Clinical Trial Update: Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating platinum-based chemotherapy plus ramucirumab in advanced non-small cell lung cancer patients who progressed after first-line a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• Ramucirumab (ramucirumab)

Snippet

Sponsor: ROGER S KERESZTES MD | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2022-05-26